A Machine Learning Model Utilizing CT Radiomics Features and Peripheral Blood Inflammatory Markers Predicts the Prognosis of Patients with Unresectable Esophageal Squamous Cell Carcinoma Undergoing PD-1 Inhibitor Combined with Concurrent Chemoradiotherapy.